4.49
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.80
High
9.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 4.49 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.49 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.45 | 4.50 | 0.05 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 4.49 | USD |
Zynerba Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 185.22M | 41.25M | 39.99M | $ - | $ - | -1.93 | -2.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 5.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.02 | 4.79 | 3.91 | 4.27 | 1,985,238 | 0.47 | 11.69% |
| 1 Month | 3.85 | 4.79 | 3.68 | 4.30 | 1,563,937 | 0.64 | 16.62% |
| 3 Months | 4.64 | 7.03 | 3.55 | 4.69 | 1,810,438 | -0.15 | -3.23% |
| 6 Months | 3.88 | 9.00 | 3.15 | 5.10 | 3,392,730 | 0.61 | 15.72% |
| 1 Year | 4.20 | 9.00 | 2.80 | 4.94 | 2,225,664 | 0.29 | 6.9% |
| 3 Years | 9.88 | 16.47 | 2.55 | 6.66 | 1,368,876 | -5.39 | -54.55% |
| 5 Years | 7.02 | 25.95 | 2.55 | 7.72 | 995,009 | -2.53 | -36.04% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |
